Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02144090
Other study ID # O2 Pilot Study
Secondary ID
Status Completed
Phase N/A
First received May 15, 2014
Last updated July 9, 2015
Start date May 2014
Est. completion date May 2015

Study information

Verified date July 2015
Source Laval University
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the usability and safety of the Opsens OptoWire and Optomonitor in measuring fractional flow reserve (FFR) in patients with coronary artery disease who are undergoing a coronary angiogram.


Description:

Fractional flow reserve (FFR) measurement involves determining the ratio between the maximum achievable blood flow in a diseased coronary artery and the theoretical maximum flow in a normal coronary artery. An FFR of 1.0 is widely accepted as normal. An FFR value lower than 0.75 - 0.80 is generally considered to be associated with myocardial ischemia (MI).

FFR is easily measured during routine coronary angiography by using a pressure wire to calculate the ratio between coronary pressure distal to a coronary artery stenosis and aortic pressure under conditions of maximum myocardial hyperemia. This ratio represents the potential decrease in coronary flow distal to the coronary stenosis.

Over the past decade, FFR measurement has been increasingly used in cardiac catheterization laboratories. It provides a quantitative assessment of the functional severity of a coronary artery stenosis identified during coronary angiography and cardiac catheterization.

Opsens, Inc. has developed a new pressure wire for use in determining FFR in coronary arteries; the OptoWire. The OptoWire is an instrumented guide wire with a fiber optic pressure sensor mounted 3.5 cm proximal to the tip. The Optowire measures blood pressure during diagnostic and/or interventional procedures when used in combination with the OptoMonitor.

The O2 study is a pilot study which aims to provide preliminary experience in human patients with coronary artery disease. The study data will also be used as part of design validation.

The O2 study is a prospective single arm study designed to assess the usability, functionality, and safety of the Optowire and Optomonitor in patients.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date May 2015
Est. primary completion date May 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with

- Stable angina or,

- Unstable angina pectoris or,

- Atypical chest pain or no chest pain but with suspected ischemia

- At least one moderate lesion in native coronary artery thought to produce ischemia

- Operator and patient agree for procedures

- Patient (> 18 years) has signed a written informed consent prior to procedure

Exclusion Criteria:

- Lesions with angiographic 'haziness' or suspected to contain thrombus

- Post-coronary artery bypass grafting

- Total occlusion

- If use of atherectomy device is indicated

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Intervention

Device:
Fractional flow reserve measurement
Fractional flow reserve measurement

Locations

Country Name City State
Canada IUCPQ - Laval Hospital Quebec

Sponsors (3)

Lead Sponsor Collaborator
Laval University International Chair on Interventional Cardiology and Transradial Approach, Opsens Medical

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Safety and handling assessment of the Optowire Safely reach and cross a target lesion;
perform an FFR measurement using the Optowire and Optomonitor according to the product user guide;
disconnect the proximal connector on the OptoWire during the procedure, placing an interventional device (if necessary), and reconnecting the Optowire proximal connector;
safely remove the Optowire from the coronary artery.
Dedicated questionnaires will be used for such assessment
Patients will be followed through removal of the OptoWire from percutaneous insertion site and completion of the cardiac catheterization procedure (expected average <1hr) Yes
Secondary Comparison of FFR values measured with Optowire vs. with FFR guide wire used in standard practice In selected cases, the operator may choose to perform FFR measurements using currently approved FFR wires. Values obtained with standard FFR wires and Optowire may therefore be compared. Patients will be followed through removal of the OptoWire from percutaneous insertion site and completion of the cardiac catheterization procedure (expected average <1hr) No
See also
  Status Clinical Trial Phase
Completed NCT04153006 - Comparison of Fingerstick Versus Venous Sample for Troponin I.
Recruiting NCT03664973 - Serratus Plane Block for Rib Fractures N/A
Completed NCT02905383 - The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT03906812 - A Randomized Trial of Telemetry Compared With Unmonitored Floor Admissions in ED Patients With Low-Risk Chest Pain N/A
Active, not recruiting NCT02892903 - In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? N/A
Completed NCT02538861 - Acute Chest Pain Imaging in the ED With the Combine CCTA and CT Perfusion
Completed NCT02538770 - Rapid Viral Diagnostics in Adults to Reduce Antimicrobial Consumption and Duration of Hospitalization N/A
Completed NCT02440893 - Understanding the Effect of Metformin on Corus CAD (or ASGES)
Completed NCT01931852 - Cardiac Magnetic Resonance Imaging Strategy for the Management of Patients With Acute Chest Pain and Detectable to Elevated Troponin N/A
Completed NCT01665521 - Efficacy Evaluation of the HEART Pathway in Emergency Department Patients With Acute Chest Pain N/A
Recruiting NCT01542086 - Comparison of the Cost-Effectiveness of Coronary CT Angiography Versus Myocardial SPECT in Patients With Intermediate Risk of Coronary Heart Disease N/A
Completed NCT01604655 - ProspEctive First Evaluation in Chest Pain Trial N/A
Completed NCT01486030 - Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
Terminated NCT01836211 - High-Sensitivity Troponin T and Coronary Computed Tomography Angiography for Rapid Diagnosis of Emergency Chest Pain N/A
Completed NCT01163019 - 2D Strain Echocardiography for Diagnosing Chest Pain in the Emergency Room N/A
Completed NCT00709670 - ComParative Diagnostic Study Between Multislice Computed Tomography (MSCT) and Stress Echography in Coronarin Patients. N/A
Completed NCT00536224 - Chest Pain Observation Unit Risk Reduction Trial N/A
Terminated NCT00221182 - Stem Cell Study for Patients With Heart Disease Phase 1/Phase 2
Completed NCT00075088 - Tele-Electrocardiography in Emergency Cardiac Care Phase 3